UCLA Hematology/Oncology - Santa Monica ( Site 0044)

Los Angeles, California 90404

2 studies enrolling now · 2 studies all time

What they study most

Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

Studies at this site

• A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004) — Recruiting now
• Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A) — Recruiting now